Which has higher earnings & valuation, VREX or PDEX?

Pro-Dex has lower revenue, but higher earnings than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Varex Imaging $844.60M 0.92 -$70.30M $0.52 35.58 Pro-Dex $77.55M 2.51 $13.66M $4.13 14.70

Is VREX or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 25.13% beat Varex Imaging's return on equity. Company Net Margins Return on Equity Return on Assets Varex Imaging 2.55% 9.19% 4.13% Pro-Dex 17.62% 25.13% 16.02%

Does the media favor VREX or PDEX?

In the previous week, Pro-Dex had 1 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for Pro-Dex and 3 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 1.79 beat Pro-Dex's score of 1.01 indicating that Varex Imaging is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Varex Imaging 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer SSII or PDEX?

In the previous week, Pro-Dex had 1 more articles in the media than SS Innovations International. MarketBeat recorded 4 mentions for Pro-Dex and 3 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.33 beat Pro-Dex's score of 1.01 indicating that SS Innovations International is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment SS Innovations International 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, ANGO or PDEX?

Pro-Dex has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio AngioDynamics $320.17M 1.98 -$36.74M -$0.87 N/A Pro-Dex $77.55M 2.51 $13.66M $4.13 14.70

Is ANGO or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to AngioDynamics' net margin of -11.48%. Pro-Dex's return on equity of 25.13% beat AngioDynamics' return on equity. Company Net Margins Return on Equity Return on Assets AngioDynamics -11.48% -5.73% -3.77% Pro-Dex 17.62% 25.13% 16.02%

Does the media prefer ANGO or PDEX?

In the previous week, Pro-Dex had 3 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Pro-Dex and 1 mentions for AngioDynamics. Pro-Dex's average media sentiment score of 1.01 beat AngioDynamics' score of 0.84 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AngioDynamics 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Is KIDS or PDEX more profitable?

Pro-Dex has a net margin of 17.62% compared to OrthoPediatrics' net margin of -15.72%. Pro-Dex's return on equity of 25.13% beat OrthoPediatrics' return on equity. Company Net Margins Return on Equity Return on Assets OrthoPediatrics -15.72% -8.10% -5.54% Pro-Dex 17.62% 25.13% 16.02%

Does the media prefer KIDS or PDEX?

In the previous week, OrthoPediatrics had 9 more articles in the media than Pro-Dex. MarketBeat recorded 13 mentions for OrthoPediatrics and 4 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.01 beat OrthoPediatrics' score of 0.50 indicating that Pro-Dex is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment OrthoPediatrics 5 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has stronger earnings and valuation, PDEX or BWAY?

Pro-Dex has higher revenue and earnings than Brainsway. Pro-Dex is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Pro-Dex $77.55M 2.51 $13.66M $4.13 14.70 Brainsway $52.22M 11.10 $7.57M $0.44 32.75

Is PDEX or BWAY more profitable?

Pro-Dex has a net margin of 17.62% compared to Brainsway's net margin of 15.65%. Pro-Dex's return on equity of 25.13% beat Brainsway's return on equity. Company Net Margins Return on Equity Return on Assets Pro-Dex 17.62% 25.13% 16.02% Brainsway 15.65% 12.74% 8.17%

Does the media refer more to PDEX or BWAY?

In the previous week, Brainsway had 4 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Brainsway and 4 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.01 beat Brainsway's score of -0.01 indicating that Pro-Dex is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Pro-Dex 1 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Brainsway 1 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Neutral

Pro-Dex (PDEX) Competitors

$60.70 -5.71 (-8.60%)

Closing price 09/9/2026 04:00 PM Eastern

Extended Trading

$60.90 +0.20 (+0.34%)

As of 09/9/2026 07:30 PM Eastern

Compare

PDEX vs. VREX, SSII, ANGO, KIDS, and BWAY

Should you buy Pro-Dex stock or one of its competitors? Pro-Dex's main competitors and comparable companies include Varex Imaging (VREX), SS Innovations International (SSII), AngioDynamics (ANGO), OrthoPediatrics (KIDS), and Brainsway (BWAY). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare equipment" industry.

How does Pro-Dex compare to Varex Imaging?

Varex Imaging (NASDAQ:VREX) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability, media sentiment and dividends.

Pro-Dex has a net margin of 17.62% compared to Varex Imaging's net margin of 2.55%. Pro-Dex's return on equity of 25.13% beat Varex Imaging's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Varex Imaging	2.55%	9.19%	4.13%
Pro-Dex	17.62%	25.13%	16.02%

Pro-Dex has lower revenue, but higher earnings than Varex Imaging. Pro-Dex is trading at a lower price-to-earnings ratio than Varex Imaging, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Varex Imaging	$844.60M	0.92	-$70.30M	$0.52	35.58
Pro-Dex	$77.55M	2.51	$13.66M	$4.13	14.70

Varex Imaging has a beta of 0.96, suggesting that its stock price is 4% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, suggesting that its stock price is 94% less volatile than the broader market.

In the previous week, Pro-Dex had 1 more articles in the media than Varex Imaging. MarketBeat recorded 4 mentions for Pro-Dex and 3 mentions for Varex Imaging. Varex Imaging's average media sentiment score of 1.79 beat Pro-Dex's score of 1.01 indicating that Varex Imaging is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Varex Imaging	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

15.3% of Pro-Dex shares are held by institutional investors. 4.6% of Varex Imaging shares are held by company insiders. Comparatively, 45.9% of Pro-Dex shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Varex Imaging presently has a consensus target price of $16.88, suggesting a potential downside of 8.78%. Pro-Dex has a consensus target price of $70.00, suggesting a potential upside of 15.32%. Given Pro-Dex's stronger consensus rating and higher possible upside, analysts clearly believe Pro-Dex is more favorable than Varex Imaging.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Varex Imaging	0 Sell rating(s)	7 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Summary

Pro-Dex beats Varex Imaging on 12 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to SS Innovations International?

SS Innovations International (NASDAQ:SSII) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and media sentiment.

Pro-Dex has a net margin of 17.62% compared to SS Innovations International's net margin of -23.73%. Pro-Dex's return on equity of 25.13% beat SS Innovations International's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
SS Innovations International	-23.73%	-26.77%	-15.01%
Pro-Dex	17.62%	25.13%	16.02%

Pro-Dex has higher revenue and earnings than SS Innovations International. SS Innovations International is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
SS Innovations International	$42.49M	15.19	-$12.13M	-$0.06	N/A
Pro-Dex	$77.55M	2.51	$13.66M	$4.13	14.70

SS Innovations International has a beta of -1.94, meaning that its share price is 294% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market.

SS Innovations International presently has a consensus price target of $7.00, suggesting a potential upside of 117.39%. Pro-Dex has a consensus price target of $70.00, suggesting a potential upside of 15.32%. Given SS Innovations International's higher probable upside, equities analysts clearly believe SS Innovations International is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
SS Innovations International	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

15.3% of Pro-Dex shares are held by institutional investors. 45.9% of Pro-Dex shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, Pro-Dex had 1 more articles in the media than SS Innovations International. MarketBeat recorded 4 mentions for Pro-Dex and 3 mentions for SS Innovations International. SS Innovations International's average media sentiment score of 1.33 beat Pro-Dex's score of 1.01 indicating that SS Innovations International is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
SS Innovations International	3 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pro-Dex beats SS Innovations International on 13 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to AngioDynamics?

AngioDynamics (NASDAQ:ANGO) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, media sentiment, risk, valuation, profitability, earnings, analyst recommendations and institutional ownership.

AngioDynamics currently has a consensus target price of $19.50, indicating a potential upside of 27.28%. Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 15.32%. Given AngioDynamics' higher probable upside, equities analysts plainly believe AngioDynamics is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AngioDynamics	2 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.40
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

89.4% of AngioDynamics shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 6.0% of AngioDynamics shares are owned by company insiders. Comparatively, 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Pro-Dex has a net margin of 17.62% compared to AngioDynamics' net margin of -11.48%. Pro-Dex's return on equity of 25.13% beat AngioDynamics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AngioDynamics	-11.48%	-5.73%	-3.77%
Pro-Dex	17.62%	25.13%	16.02%

AngioDynamics has a beta of 0.33, indicating that its stock price is 67% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, indicating that its stock price is 94% less volatile than the broader market.

Pro-Dex has lower revenue, but higher earnings than AngioDynamics. AngioDynamics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AngioDynamics	$320.17M	1.98	-$36.74M	-$0.87	N/A
Pro-Dex	$77.55M	2.51	$13.66M	$4.13	14.70

In the previous week, Pro-Dex had 3 more articles in the media than AngioDynamics. MarketBeat recorded 4 mentions for Pro-Dex and 1 mentions for AngioDynamics. Pro-Dex's average media sentiment score of 1.01 beat AngioDynamics' score of 0.84 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AngioDynamics	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Pro-Dex beats AngioDynamics on 11 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to OrthoPediatrics?

OrthoPediatrics (NASDAQ:KIDS) and Pro-Dex (NASDAQ:PDEX) are both small-cap healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, profitability, earnings, analyst recommendations, valuation and institutional ownership.

Pro-Dex has a net margin of 17.62% compared to OrthoPediatrics' net margin of -15.72%. Pro-Dex's return on equity of 25.13% beat OrthoPediatrics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
OrthoPediatrics	-15.72%	-8.10%	-5.54%
Pro-Dex	17.62%	25.13%	16.02%

OrthoPediatrics currently has a consensus target price of $26.44, indicating a potential upside of 21.98%. Pro-Dex has a consensus target price of $70.00, indicating a potential upside of 15.32%. Given OrthoPediatrics' stronger consensus rating and higher probable upside, research analysts clearly believe OrthoPediatrics is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
OrthoPediatrics	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67

Pro-Dex has lower revenue, but higher earnings than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Pro-Dex, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
OrthoPediatrics	$236.35M	2.40	-$39.65M	-$1.68	N/A
Pro-Dex	$77.55M	2.51	$13.66M	$4.13	14.70

OrthoPediatrics has a beta of 0.99, indicating that its share price is 1% less volatile than the broader market. Comparatively, Pro-Dex has a beta of 0.06, indicating that its share price is 94% less volatile than the broader market.

In the previous week, OrthoPediatrics had 9 more articles in the media than Pro-Dex. MarketBeat recorded 13 mentions for OrthoPediatrics and 4 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.01 beat OrthoPediatrics' score of 0.50 indicating that Pro-Dex is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
OrthoPediatrics	5 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

69.1% of OrthoPediatrics shares are owned by institutional investors. Comparatively, 15.3% of Pro-Dex shares are owned by institutional investors. 32.5% of OrthoPediatrics shares are owned by company insiders. Comparatively, 45.9% of Pro-Dex shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Pro-Dex beats OrthoPediatrics on 9 of the 16 factors compared between the two stocks.

How does Pro-Dex compare to Brainsway?

Pro-Dex (NASDAQ:PDEX) and Brainsway (NASDAQ:BWAY) are both small-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, media sentiment, earnings, profitability, valuation, risk, institutional ownership and dividends.

In the previous week, Brainsway had 4 more articles in the media than Pro-Dex. MarketBeat recorded 8 mentions for Brainsway and 4 mentions for Pro-Dex. Pro-Dex's average media sentiment score of 1.01 beat Brainsway's score of -0.01 indicating that Pro-Dex is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Pro-Dex	1 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Brainsway	1 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Neutral

Pro-Dex currently has a consensus price target of $70.00, suggesting a potential upside of 15.32%. Brainsway has a consensus price target of $18.20, suggesting a potential upside of 26.30%. Given Brainsway's stronger consensus rating and higher possible upside, analysts clearly believe Brainsway is more favorable than Pro-Dex.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Pro-Dex	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
Brainsway	0 Sell rating(s)	2 Hold rating(s)	5 Buy rating(s)	0 Strong Buy rating(s)	2.71

Pro-Dex has a beta of 0.06, meaning that its share price is 94% less volatile than the broader market. Comparatively, Brainsway has a beta of 1.25, meaning that its share price is 25% more volatile than the broader market.

15.3% of Pro-Dex shares are owned by institutional investors. Comparatively, 30.1% of Brainsway shares are owned by institutional investors. 45.9% of Pro-Dex shares are owned by company insiders. Comparatively, 19.0% of Brainsway shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Pro-Dex has a net margin of 17.62% compared to Brainsway's net margin of 15.65%. Pro-Dex's return on equity of 25.13% beat Brainsway's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Pro-Dex	17.62%	25.13%	16.02%
Brainsway	15.65%	12.74%	8.17%

Pro-Dex has higher revenue and earnings than Brainsway. Pro-Dex is trading at a lower price-to-earnings ratio than Brainsway, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Pro-Dex	$77.55M	2.51	$13.66M	$4.13	14.70
Brainsway	$52.22M	11.10	$7.57M	$0.44	32.75

Summary

Pro-Dex and Brainsway tied by winning 8 of the 16 factors compared between the two stocks.

Get Pro-Dex News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PDEX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

PDEX vs. The Competition

Export

Metric	Pro-Dex	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$212.73M	$5.57B	$7.22B	$12.88B
Dividend Yield	N/A	1.78%	2.55%	9.95%
P/E Ratio	14.70	24.83	271.79	25.29
Price / Sales	2.51	71.76	709.72	113.02
Price / Cash	17.01	32.78	77.55	52.32
Price / Book	4.07	6.00	10.63	6.26
Net Income	$13.66M	$150.94M	$3.48B	$357.86M
7 Day Performance	-1.70%	-1.91%	-1.19%	-0.56%
1 Month Performance	-8.38%	-2.05%	1.99%	-1.04%
1 Year Performance	70.03%	9.12%	21.89%	11.31%

Pro-Dex Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
PDEX Pro-Dex	2.2842 of 5 stars	$60.70 -8.6%	$70.00 +15.3%	+66.8%	$212.73M	$77.55M	14.70	140	Positive News Earnings Report High Trading Volume
VREX Varex Imaging	2.3969 of 5 stars	$18.47 -0.1%	$16.88 -8.6%	+59.6%	$778.43M	$865M	35.52	2,400	Positive News
SSII SS Innovations International	2.543 of 5 stars	$3.34 -2.1%	$7.00 +109.6%	-52.3%	$683.31M	$42.49M	N/A	4	Positive News
ANGO AngioDynamics	2.9341 of 5 stars	$15.86 -1.7%	$19.50 +23.0%	+39.1%	$666.69M	$320.17M	N/A	760	Positive News
KIDS OrthoPediatrics	3.4914 of 5 stars	$23.00 -1.3%	$26.44 +15.0%	+5.8%	$608.62M	$252.72M	N/A	200

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:PDEX) was last updated on 9/10/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Pro-Dex (PDEX) Competitors

PDEX vs. VREX, SSII, ANGO, KIDS, and BWAY

How does Pro-Dex compare to Varex Imaging?

Summary

How does Pro-Dex compare to SS Innovations International?

Summary

How does Pro-Dex compare to AngioDynamics?

Summary

How does Pro-Dex compare to OrthoPediatrics?

Summary

How does Pro-Dex compare to Brainsway?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Pro-Dex (PDEX) Competitors

PDEX vs. VREX, SSII, ANGO, KIDS, and BWAY

How does Pro-Dex compare to Varex Imaging?

Is VREX or PDEX more profitable?

Which has higher earnings & valuation, VREX or PDEX?

Which has more volatility and risk, VREX or PDEX?

Does the media favor VREX or PDEX?

Do institutionals and insiders hold more shares of VREX or PDEX?

Do analysts recommend VREX or PDEX?

Summary

How does Pro-Dex compare to SS Innovations International?

Is SSII or PDEX more profitable?

Which has higher valuation and earnings, SSII or PDEX?

Which has more risk and volatility, SSII or PDEX?

Do analysts rate SSII or PDEX?

Do institutionals & insiders have more ownership in SSII or PDEX?

Does the media prefer SSII or PDEX?

Summary

How does Pro-Dex compare to AngioDynamics?

Do analysts prefer ANGO or PDEX?

Do institutionals and insiders have more ownership in ANGO or PDEX?

Is ANGO or PDEX more profitable?

Which has more risk and volatility, ANGO or PDEX?

Which has preferable earnings and valuation, ANGO or PDEX?

Does the media prefer ANGO or PDEX?

Summary

How does Pro-Dex compare to OrthoPediatrics?

Is KIDS or PDEX more profitable?

Do analysts prefer KIDS or PDEX?

Which has better earnings & valuation, KIDS or PDEX?

Which has more volatility & risk, KIDS or PDEX?

Does the media prefer KIDS or PDEX?

Do insiders & institutionals have more ownership in KIDS or PDEX?

Summary

How does Pro-Dex compare to Brainsway?

Does the media refer more to PDEX or BWAY?

Do analysts prefer PDEX or BWAY?

Which has more risk and volatility, PDEX or BWAY?

Do institutionals and insiders hold more shares of PDEX or BWAY?

Is PDEX or BWAY more profitable?

Which has stronger earnings and valuation, PDEX or BWAY?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

PDEX vs. The Competition

Pro-Dex Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools